Sirt5 KO induces increased lysine succinylation and decreased ATP synthase activity in mouse heart mitochondria. by Mengli Zhang (6331172)

Depletion of EphA3 or EphA4 recovers the decreased ERK and Akt activation and lytic gene expression in RNF5 KO PEL cells. by Xiaojuan Li (351842)

Decrease in CLPs, NKPS and Block in NKP progression. by John Richards (53768)

BA decreases DUB activity in PC cells. by Teresita Reiner (281437)

“…(<b>B</b>) DUB assay showed that BA treatment of LNCaP cells significantly decreased DUB activity at 24 and 48 h relative to control treated cells ( = 1) (*, <i>P</i><5×10⁻⁵). …”

Complex I inhibitor decreases ROS level by Zheng Li (26302)

PI+ total immune cells are decreased at days 2, 5, and 14 following IR, and PI+ neutrophils are increased at day 30. by Jordan A. Gunning (18143970)

Decrease of myopia progression with 0.025% atropine by Celso Marcelo da Cunha (4894324)

TIMP-4 overexpression decreases cell viability. by Floria Lizarraga (785275)

Decrease of ERK phosphorylation by NOS inhibitor TRIM. by Immacolata Castellano (603814)

Knockdown of p65 in A549 cells results in a decreased infection rate. by Janine J. Wilden (8849948)

Results isoprenaline (30nM) experiment. by L. Cao (3526226)

Decreased neutrophils in <i>MiR125a</i>^<i>-/-</i> mice. by Yuting Qin (1950118)

Comparison of estimated arterial cerebral blood volumes (aCBVs) (Mean ± SD^*) between multiphase bSSFP and AVAST (N = 5). by Ki Hwan Kim (427869)

Loss of either isoform of PLD decreases phagocytosis. by Wahida H. Ali (286470)

MES transiently decreases mitochondrial membrane potential. by Shingo Matsuyama (672132)

GSH content was decreased in low glucose conditions. by Martine Emery (215947)

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”

Reduced expression of Tks5 leads to decreased growth of tumor cells <i>in vitro</i> and <i>in vivo</i>. by Barbara Blouw (715467)

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

“…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”

Dopamine decreases the refractive power in the lens periphery. by J. Marcus Schartau (365288)

“…<p>(A) The mean ΔBCD curves describe the difference between the treated and untreated lenses from all animals (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0010402#s4" target="_blank">Methods and Materials</a>). …”